These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12483109)

  • 21. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
    Robinson LJ; Xue J; Corey SJ
    Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myeloid leukemia and acute promyelocytic leukemia.
    Löwenberg B; Griffin JD; Tallman MS
    Hematology Am Soc Hematol Educ Program; 2003; ():82-101. PubMed ID: 14633778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
    Kaspers GJ; Zwaan CM
    Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLT3 mutations are associated with other molecular lesions in AML.
    Carnicer MJ; Nomdedéu JF; Lasa A; Estivill C; Brunet S; Aventín A; Sierra J
    Leuk Res; 2004 Jan; 28(1):19-23. PubMed ID: 14630076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
    Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia.
    Jamal R; Taketani T; Taki T; Bessho F; Hongo T; Hamaguchi H; Horiike S; Taniwaki M; Hanada R; Nakamura H; Hayashi Y
    Genes Chromosomes Cancer; 2001 Jun; 31(2):187-90. PubMed ID: 11319806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current and new therapeutic strategies in acute myeloid leukemia].
    Naito K; Ohnishi K
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):292-6. PubMed ID: 15791811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLT3 inhibition as a targeted therapy for acute myeloid leukemia.
    Sanz M; Burnett A; Lo-Coco F; Löwenberg B
    Curr Opin Oncol; 2009 Nov; 21(6):594-600. PubMed ID: 19684517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis of leukemia.
    Gilliland DG; Jordan CT; Felix CA
    Hematology Am Soc Hematol Educ Program; 2004; ():80-97. PubMed ID: 15561678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult acute myeloid leukemia.
    Jabbour EJ; Estey E; Kantarjian HM
    Mayo Clin Proc; 2006 Feb; 81(2):247-60. PubMed ID: 16471082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia.
    Sawyers CL
    Cancer Cell; 2002 Jun; 1(5):413-5. PubMed ID: 12124170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
    Hu ZB; Quentmeier H; Meyer C; Kaufmann M; MacLeod RA; Drexler HG
    Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent progress of study on retroviral mediated mouse model of myeloid leukemia --- review].
    Shi L; Wang YY; Chen SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1058-63. PubMed ID: 21867644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing target therapy against oncogenic tyrosine kinase in myeloid maliganacies.
    Naoe T
    Curr Pharm Biotechnol; 2006 Oct; 7(5):331-7. PubMed ID: 17076649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
    Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA
    Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging treatments in acute myeloid leukaemia.
    Kell J
    Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.